Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Avenue Therapeutics, Inc. is a specialty pharmaceutical company developing therapies for neurologic diseases. Its pipeline includes AJ201 for spinal and bulbar muscular atrophy, IV tramadol for postoperative acute pain, and BAER-101 for epilepsy and panic disorders. Avenue focuses on advancing clinical-stage drug candidates with novel mechanisms, targeting unmet medical needs in neurology and pain management, leveraging licensing agreements and clinical development to bring innovative treatments to market.
This description was generated via AI from an annual report. Updated about 1 year ago.